C
CANDEL THERAPEUTICS INC
NASDAQ: CADL (Candel Therapeutics, Inc.)
Kemas kini terakhir: 4 jam lalu13.13
0.78 (6.32%)
| Penutupan Terdahulu | 12.35 |
| Buka | 12.65 |
| Jumlah Dagangan | 1,335,277 |
| Purata Dagangan (3B) | 1,655,411 |
| Modal Pasaran | 1,004,688,832 |
| Harga / Jualan (P/S) | 436.42 |
| Harga / Buku (P/B) | 7.37 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2026 |
| EPS Cair (TTM) | -1.33 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 14.61% |
| Nisbah Semasa (MRQ) | 4.64 |
| Aliran Tunai Operasi (OCF TTM) | -27.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.33 M |
| Pulangan Atas Aset (ROA TTM) | -32.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -98.14% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Candel Therapeutics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
-0.5
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | -0.50 |
|
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 17.53% |
| % Dimiliki oleh Institusi | 40.72% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Halter Ferguson Financial Inc. | 30 Jun 2026 | 772,461 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| TYAGARAJAN SESHU | - | 12.16 | -7,000 | -85,120 |
| Jumlah Keseluruhan Kuantiti Bersih | -7,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -85,120 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 12.16 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| TYAGARAJAN SESHU | Pegawai | 17 Aug 2026 | Jual automatik (-) | 7,000 | 12.16 | 85,120 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |